![PDF) Selecting the optimal antithrombotic regimen for patients with acute coronary syndromes undergoing percutaneous coronary intervention PDF) Selecting the optimal antithrombotic regimen for patients with acute coronary syndromes undergoing percutaneous coronary intervention](https://i1.rgstatic.net/publication/26767338_Selecting_the_optimal_antithrombotic_regimen_for_patients_with_acute_coronary_syndromes_undergoing_percutaneous_coronary_intervention/links/5788a48008ae21394a0fa3bd/largepreview.png)
PDF) Selecting the optimal antithrombotic regimen for patients with acute coronary syndromes undergoing percutaneous coronary intervention
![Disease consequences of higher adiposity uncoupled from its adverse metabolic effects using Mendelian randomisation | eLife Disease consequences of higher adiposity uncoupled from its adverse metabolic effects using Mendelian randomisation | eLife](https://iiif.elifesciences.org/lax:72452%2Felife-72452-fig4-v1.tif/full/1500,/0/default.jpg)
Disease consequences of higher adiposity uncoupled from its adverse metabolic effects using Mendelian randomisation | eLife
![Disease consequences of higher adiposity uncoupled from its adverse metabolic effects using Mendelian randomisation | eLife Disease consequences of higher adiposity uncoupled from its adverse metabolic effects using Mendelian randomisation | eLife](https://iiif.elifesciences.org/lax:72452%2Felife-72452-fig1-v1.tif/full/,1500/0/default.jpg)